Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device.
Diabetic retinopathy (DR) is a leading cause of blindness among working-age adults. Therefore, it is important to detect DR accurately during mass screening. The purpose of this study was to determine whether a small, hand-held, mydriasis-free, full-field flicker electroretinographic (ERGs) device called RETeval can be used to screen for DR. To accomplish this, we recorded full-field flicker ERGs with this device from 48 normal eyes and 118 eyes with different severities of DR in patients with diabetes mellitus (DM). This system delivered a constant flash retinal luminance by adjusting the flash luminance that compensated for changes in the pupil size. Our results showed that there were significant correlations between the severity of DR and the implicit times (P < 0.001; r = 0.55) and the amplitudes (P = 0.001; r = -0.29). When the implicit time was used for the index, the area under the receiver operating characteristic curve was 0.84 for the detection of DR, and was 0.89 for the detection of DR requiring ophthalmic treatments. These results suggest that the implicit times of the flicker ERGs recorded by the small, mydryasis-free ERG system can be used as an adjunctive tool to screen for DR.
Department of Diabetic Ophthalmology, Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
Motonobu
M
Fukuo
Department of Ophthalmology, Mie University Graduate School of Medicine, Tsu, Japan.
Mineo
M
Kondo
Department of Diabetic Ophthalmology, Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
Akira
A
Hirose
Department of Diabetic Ophthalmology, Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
Harumi
H
Fukushima
Department of Ophthalmology, Mie University Graduate School of Medicine, Tsu, Japan.
Kengo
K
Ikesugi
Department of Ophthalmology, Mie University Graduate School of Medicine, Tsu, Japan.
Masahiko
M
Sugimoto
Department of Ophthalmology, Mie University Graduate School of Medicine, Tsu, Japan.
Kumiko
K
Kato
Diabetes Center, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Yasuko
Y
Uchigata
Department of Diabetic Ophthalmology, Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
Shigehiko
S
Kitano
D000328:Adult; D003930:Diabetic Retinopathy / Q000503:physiopathology*; D004596:Electroretinography / Q000295:instrumentation* / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012160:Retina / Q000503:physiopathology*